OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms

About this update from Optimizerx Corporation

Patent-pending, embeddable NLAB technology enables pharma and agency marketers to build custom, verified HCP audiences using natural-language prompts WALTHAM, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare providers (HCPs) and patients at the most important decision points, today announced the launch of its patent-pending Natural Language Audience Builder (NLAB), an AI-powered tool designed to be embedded within both demand-side platforms (DSPs) and agency media planning platforms. NLAB combines real-world evidence with proprietary data from OptimizeRx's best-in-class EHR network so life sciences companies and agency marketers can better create and manage custom HCP audiences within the media planning and buying platforms they already use. By connecting audience intelligence to point of care reach, NLAB helps identify the right providers and activate messages in the clinical workflows where prescribing decisions are made. With NLAB, marketers can: This technology launch builds on OptimizeRx's prior announcement opening programmatic access to its authenticated EHR inventory and expands the Company's role as an infrastructure partner for life sciences manufacturers, agencies, and DSPs serving the healthcare ecosystem. "Healthcare marketers need a faster way to build audiences that reflect the strategy behind each campaign, without relying on 'good enough' pre-built segments," said Mike Rousselle, Chief AI Officer at OptimizeRx. "By embedding this capability into DSP and media planning platforms, we are giving pharma and agency teams an easier, more intuitive way to build custom HCP audiences, while helping DSPs bring stronger healthcare intelligence into the workflows their clients already use." "DSPs represent an important growth channel for OptimizeRx as more healthcare media investment moves through programmatic platforms," said Stephen Silvestro, CEO of OptimizeRx. "By embedding audience intelligence alongside our EHR inventory directly into DSP workflows, we can help our partners deliver more differentiated value to pharma and agency clients while creating new recurring revenue streams for our business."

View stock analysis, news, and events for Optimizerx Corporation